查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1377370

生育補充劑市場 - 全球產業規模、佔有率、趨勢、機會和預測，2018-2028 年按成分、產品、最終用途、配銷通路、地區、競爭預測和機會細分，2018-2028F

Fertility Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Ingredient, By Product, By End-use, By Distribution Channel, By Region, By Competition Forecast & Opportunities, 2018-2028F
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年，全球生育補充品市場價值為 18.7 億美元，預計在預測期內將出現令人印象深刻的成長，到 2028 年，複合CAGR為6.29%。預計未來幾年，生育率下降將推動市場成長。吸煙者的增加以及酒精和咖啡因消費量的增加。醫療保健成本上升、生活方式不斷變化、食品創新以及醫療技術進步等因素也導致了對這些產品的需求不斷成長。此外，由於女性延遲懷孕和生育率持續下降，全球生育補充品市場正在擴大。有趣的是，COVID-19 大流行對生育補充劑的需求產生了有利影響，因為研究表明該病毒可能會影響個人的生育能力。此外，2021 年1 月發表的一項題為「鋅在COVID-19 疾病過程中的潛在作用及其對生殖的可能影響」的研究表明，鋅補充劑可以減輕人體免疫反應對卵子和精子細胞造成的損害。冠狀病毒，從而增強免疫力。這些研究結果導致大流行期間對生育補充劑的需求增加，對市場產生了積極影響。

主要市場促進因素

生育問題日益嚴重

市場概況
預測期 2024-2028
2022 年市場規模 18.7億美元
2028 年市場規模 26.7億美元
2023-2028 年CAGR 6.29%
成長最快的細分市場 場外交易
最大的市場 北美洲

近年來，在個人和夫婦對生育問題的驚人成長的推動下，全球生育補充劑市場出現了大幅成長。由於生活方式的改變、計劃生育延遲和壓力水平升高等因素影響生殖健康，人們擴大將生育補充劑作為潛在的解決方案。推動生育補充劑市場成長的重要因素之一是人口結構的變化。在許多已開發國家，延遲生育的趨勢非常明顯。夫婦們要等到二十多歲或三十多歲時才開始建立家庭。雖然這種趨勢往往受到職業目標和經濟因素的影響，但它也帶來了與年齡相關的生育挑戰。隨著女性年齡的成長，她們的生育能力下降，使受孕變得更加困難。這種人口結構的變化導致老年夫婦對生育補充劑的需求激增，以提高成功受孕的機會。現代生活方式的特點是壓力大、久坐和不良飲食選擇。這些因素會對生殖健康產生負面影響。眾所周知，壓力尤其會破壞荷爾蒙平衡並影響生育能力。隨著人們對這些與生活方式相關的生育問題的認知不斷增強，個人和夫婦正在尋找減輕這些影響的方法。生育補充劑通常由維生素、礦物質和草藥萃取物配製而成，被認為是支持生殖健康的天然且容易取得的手段。由於各種個人和職業方面的考慮，許多夫婦現在在開始為人父母之前要等待更長的時間。然而，這種延遲可能會導致生育問題的增加，特別是對於 35 歲以上的女性。生育補充劑被視為在嘗試受孕之前最佳化生殖健康的主動措施。因此，這些補充劑已成為許多夫妻計劃生育過程中不可或缺的一部分。人們對生育問題和生育補充劑潛在益處的更多認知在市場成長中發揮了關鍵作用。現在可以透過網路和社群媒體輕鬆取得有關生育問題和可用解決方案的資訊。這使個人和夫婦能夠掌控自己的生殖健康，並探索生育補充劑等選項來滿足他們的特定需求。電子商務的興起使得生育補充劑的購買變得更加容易和方便。消費者可以線上上研究、比較和訂購各種產品，無需親自前往商店或藥房。這種便捷的取得方式促進了市場的擴張，使更廣泛的消費者群體能夠獲得生育補充劑。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球生育補充劑市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依成分（天然、合成/天然與合成的混合物）
    • 依產品（膠囊、錠劑、軟膠囊、粉末、液體）
    • 依最終用途（男性、女性）
    • 依配銷通路（OTC、規定）
    • 按地區
    • 按公司分類 (2022)
  • 產品市場地圖
    • 按成分
    • 按產品分類
    • 按最終用途
    • 按配銷通路
    • 按地區

第 6 章：北美生育補充品市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依成分（天然、合成/天然與合成的混合物）
    • 依產品（膠囊、錠劑、軟膠囊、粉末、液體）
    • 依最終用途（男性、女性）
    • 依配銷通路（OTC、規定）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲生育補充劑市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依成分（天然、合成/天然與合成的混合物）
    • 依產品（膠囊、錠劑、軟膠囊、粉末、液體）
    • 依最終用途（男性、女性）
    • 依配銷通路（OTC、規定）
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第 8 章：亞太地區生育補充品市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依成分（天然、合成/天然與合成的混合物）
    • 依產品（膠囊、錠劑、軟膠囊、粉末、液體）
    • 依最終用途（男性、女性）
    • 依配銷通路（OTC、規定）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國

第 9 章：南美洲生育補充劑市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依成分（天然、合成/天然與合成的混合物）
    • 依產品（膠囊、錠劑、軟膠囊、粉末、液體）
    • 依最終用途（男性、女性）
    • 依配銷通路（OTC、規定）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲生育補充品市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依成分（天然、合成/天然與合成的混合物）
    • 依產品（膠囊、錠劑、軟膠囊、粉末、液體）
    • 依最終用途（男性、女性）
    • 依配銷通路（OTC、規定）
    • 按國家/地區
  • MEA：國家分析
    • 南非生育補充劑
    • 沙烏地阿拉伯生育補充劑
    • 阿拉伯聯合大公國生育補充劑
    • 科威特生育補充劑

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • Fairhaven Health LLC
    • Coastal Sciences
    • LENUS Pharma GesmbH
    • Orthomol Pharmazeutische Vertriebs GmbH
    • Exeltis USA Inc
    • PrepMe LLC
    • Bionova Inc
    • TTK Healthcare Ltd
    • Vitabiotics Ltd
    • VH Nutrition LLC

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄
Product Code: 16072

Global Fertility Supplements Market has valued at USD 1.87 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.29% through 2028. The market growth is expected to be driven in the upcoming years by decreasing fertility rates attributed to an increase in smokers and the growing consumption of alcohol and caffeine. Factors such as elevated healthcare costs, evolving lifestyles, innovations in food, and advancements in medical technology have also contributed to the rising demand for these products. Furthermore, the global fertility supplements market is expanding due to delayed pregnancies among women and ongoing declines in fertility rates. Interestingly, the COVID-19 pandemic had a favorable effect on the demand for fertility supplements, as research indicated that the virus could affect an individual's fertility. Additionally, a study published in January 2021, titled "The Potential Role of Zinc in the COVID-19 Disease Process and its Likely Impact on Reproduction," suggested that zinc supplements could mitigate damage to egg and sperm cells caused by the body's immune response to the coronavirus, thereby enhancing immunity. Such research findings have led to an increased demand for fertility supplements during the pandemic, positively influencing the market.

Key Market Drivers

Rising Fertility Concerns

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.87 Billion
Market Size 2028USD 2.67 Billion
CAGR 2023-20286.29%
Fastest Growing SegmentOTC
Largest MarketNorth America

In recent years, the global fertility supplements market has witnessed substantial growth, driven by an alarming increase in fertility concerns among individuals and couples. With factors like lifestyle changes, delayed family planning, and heightened stress levels affecting reproductive health, people are increasingly turning to fertility supplements as a potential solution. One of the significant factors driving the growth of the fertility supplements market is changing demographics. In many developed countries, there is a notable trend toward delayed childbearing. Couples are waiting until their late 20s or 30s to start their families. While this trend is often influenced by career goals and economic factors, it also comes with age-related fertility challenges. As women age, their fertility declines, making conception more difficult. This demographic shift has led to a surge in demand for fertility supplements among older couples looking to enhance their chances of successful conception. Modern lifestyles are marked by high levels of stress, sedentary routines, and poor dietary choices. These factors can have a negative impact on reproductive health. Stress, in particular, is known to disrupt hormonal balance and affect fertility. As awareness of these lifestyle-related fertility issues grows, individuals and couples are seeking ways to mitigate these effects. Fertility supplements, often formulated with vitamins, minerals, and herbal extracts, are perceived as a natural and accessible means to support reproductive health. Many couples are now waiting longer before embarking on parenthood due to various personal and professional considerations. However, this delay can lead to increased fertility concerns, especially for women over the age of 35. Fertility supplements are seen as a proactive measure to optimize reproductive health before attempting conception. As a result, these supplements have become an integral part of the family planning journey for many couples. Greater awareness about fertility issues and the potential benefits of fertility supplements has played a pivotal role in market growth. Information about fertility concerns and available solutions is now readily accessible through the internet and social media. This has empowered individuals and couples to take charge of their reproductive health and explore options like fertility supplements to address their specific needs. The rise of e-commerce has made fertility supplements more accessible and convenient to purchase. Consumers can research, compare, and order a wide range of products online, eliminating the need for physical visits to stores or pharmacies. This ease of access has contributed to the market's expansion, making fertility supplements available to a broader consumer base.

Delayed Childbearing

Delayed childbearing, a phenomenon increasingly prevalent in today's society, has far-reaching implications, not only for individuals and couples but also for the global fertility supplements market. As people around the world are choosing to start their families later in life, the demand for fertility supplements is on the rise. One of the most significant drivers of the growth in the fertility supplements market is the age-related fertility challenges that come with delayed childbearing. Many individuals and couples are waiting until their late 20s, 30s, or even 40s to have children. However, female fertility decreases with age, with a more pronounced decline after the age of 35. This reality has led to an increased awareness of the potential difficulties in conceiving later in life, prompting many to seek solutions to boost their chances of successful conception. As more people delay childbearing, there has been a parallel increase in awareness about reproductive health. Couples are taking proactive steps to understand and address their fertility concerns. They are seeking information about the factors that affect fertility and the various methods available to improve their chances of conceiving. Fertility supplements, formulated with vitamins, minerals, and herbal extracts, have emerged as a popular choice for individuals and couples looking to optimize their reproductive health. Fertility supplements are viewed as a supplemental support for fertility and reproductive well-being. They are often chosen for their potential to provide essential nutrients that may be lacking in one's diet or to address specific fertility-related issues. For individuals and couples who are delaying childbearing, these supplements can be an attractive option to bridge potential nutritional gaps and enhance their overall reproductive health. Manufacturers of fertility supplements have recognized the changing demographics and are tailoring their marketing strategies accordingly. They are targeting a specific demographic of older parents or individuals trying to conceive later in life. This targeted approach includes educational content, testimonials, and messaging that speaks to the unique concerns of this group, further driving demand for fertility supplements. Healthcare professionals are also playing a role in boosting the growth of the fertility supplements market. Many doctors and fertility specialists now recommend fertility supplements as part of preconception planning for individuals and couples, especially those who are starting their families later in life. These recommendations carry significant weight and instill confidence in the efficacy of these products.

Accessibility Through E-commerce

The global fertility supplements market is experiencing a significant transformation, largely driven by the rapid expansion of e-commerce. In recent years, accessibility through online platforms has played a pivotal role in facilitating the growth of this market. One of the most compelling reasons for the growth of the fertility supplements market through e-commerce is the unparalleled convenience it offers to consumers. In the past, individuals seeking fertility supplements would have to physically visit stores, pharmacies, or specialty shops. With e-commerce, they can now research, compare, and purchase a wide range of products from the comfort of their homes or on the go, simply by using a computer or mobile device. This convenience factor has significantly expanded the customer base. E-commerce transcends geographical boundaries, providing access to a global marketplace. Consumers are no longer limited to the selection available in their local stores. They can explore a vast array of fertility supplements from different manufacturers and regions, enabling them to find products that best suit their needs and preferences. This global reach has amplified competition and product diversity within the market. E-commerce platforms provide a wealth of information about fertility supplements. Consumers can access detailed product descriptions, ingredient lists, usage instructions, and customer reviews. This transparency empowers consumers to make informed choices, ensuring that they select products that align with their specific requirements. Moreover, the availability of customer reviews offers valuable insights into the efficacy and reliability of different supplements. Fertility is a deeply personal and sometimes sensitive topic. E-commerce offers a level of privacy and discretion that may not be attainable in physical stores. Individuals and couples can discreetly browse, research, and purchase fertility supplements without feeling self-conscious or exposed. This aspect of e-commerce has resonated with many consumers and has led to increased sales within the fertility supplements market. Many e-commerce platforms offer subscription services and auto-ship programs, allowing consumers to receive their chosen fertility supplements regularly without the hassle of placing orders repeatedly. This automated approach not only ensures a consistent supply of supplements but also fosters brand loyalty and repeat business. E-commerce fosters competition among sellers, which often results in competitive pricing. Consumers can compare prices across multiple platforms, enabling them to find the best deals and discounts. This price transparency has made fertility supplements more affordable and accessible to a wider audience.

Recommendations from Healthcare Professionals

The global fertility supplements market has experienced substantial growth in recent years, driven in part by an unlikely ally-healthcare professionals. As more individuals and couples grapple with fertility concerns, the endorsement and guidance of healthcare experts are playing a crucial role in propelling the market forward. Healthcare professionals, including doctors, obstetricians, gynecologists, and fertility specialists, are highly trusted sources of medical advice. When they recommend or endorse specific fertility supplements, it adds a layer of credibility and trustworthiness to these products. Patients often place great faith in the expertise and guidance of their healthcare providers, making them more likely to consider and use fertility supplements as part of their reproductive health journey. Fertility is a highly individualized concern, and healthcare professionals are well-equipped to provide personalized guidance to patients. When healthcare providers recommend fertility supplements, they can tailor their recommendations to the unique needs and circumstances of each patient. This personalized approach ensures that individuals receive the most appropriate and effective supplements for their specific fertility challenges. In some cases, fertility supplements are integrated into broader fertility treatment plans. Healthcare professionals may prescribe or recommend supplements alongside other interventions, such as assisted reproductive technologies or lifestyle modifications. This holistic approach reinforces the importance of fertility supplements in addressing specific fertility issues and encourages patient compliance. Healthcare professionals can monitor and evaluate the impact of fertility supplements on their patients' reproductive health. Through regular check-ups and diagnostic tests, they can assess the effectiveness of the supplements and make necessary adjustments to treatment plans. This ongoing monitoring reinforces patient confidence in the products and their healthcare providers. Fertility supplements often contain vitamins, minerals, and other nutrients that are essential for reproductive health. Healthcare professionals can identify nutritional gaps in their patients' diets through blood tests and assessments. When deficiencies are detected, they may recommend supplements as a means to bridge these gaps, promoting better overall health and fertility. Many fertility clinics and centers have established partnerships with supplement manufacturers. They offer patients access to high-quality fertility supplements that are specifically recommended by their healthcare providers. These collaborations provide patients with a seamless and trusted source for their supplement needs, further promoting the growth of the fertility supplements market. Healthcare professionals play a critical role in educating their patients about the benefits and risks of fertility supplements. They can provide guidance on proper usage, potential side effects, and interactions with other medications or treatments. This education empowers patients to make informed decisions about the supplements they choose to use.

Key Market Challenges

Regulatory Oversight

One of the most significant challenges facing the fertility supplements market is the lack of consistent and stringent regulatory oversight. Unlike pharmaceutical drugs, dietary supplements are subject to less rigorous scrutiny in many countries. This disparity raises concerns about the safety, efficacy, and quality of fertility supplements. Inconsistent regulations make it challenging for consumers to distinguish between reliable products and potentially harmful ones.

Lack of Scientific Evidence

While some fertility supplements claim to enhance reproductive health, the scientific evidence supporting their efficacy is often limited or inconclusive. The absence of robust clinical trials and long-term studies makes it difficult to ascertain the true benefits and risks of these products. This lack of scientific backing can undermine consumer confidence and trust in the industry.

Variability in Product Quality

The quality of fertility supplements can vary significantly from one brand to another. Subpar manufacturing processes, inadequate quality control, and questionable sourcing of ingredients can lead to inconsistent product quality. This variability raises concerns about the purity, potency, and safety of fertility supplements, making it challenging for consumers to make informed choices.

Misleading Marketing Claims

In the absence of strict regulations, some manufacturers engage in misleading or exaggerated marketing practices. Claims about the miraculous benefits of fertility supplements can create unrealistic expectations among consumers. Misleading marketing not only erodes trust but also poses potential health risks when individuals rely solely on supplements to address fertility concerns, instead of seeking proper medical advice and interventions.

Key Market Trends

Science-Backed Formulations

With growing scrutiny on the efficacy of fertility supplements, there is a clear trend toward science-backed formulations. Consumers are increasingly seeking products supported by rigorous clinical trials and research. Manufacturers are responding by investing in studies to provide evidence of the benefits of their supplements, instilling greater trust among consumers and healthcare professionals.

Plant-Based and Natural Ingredients

The preference for natural and plant-based ingredients is gaining traction in the fertility supplements market. Consumers are becoming more health-conscious and environmentally aware, leading to increased demand for supplements that rely on natural sources such as herbal extracts, antioxidants, and vitamins. This trend aligns with the broader movement toward cleaner and more sustainable living.

Male Fertility Supplements

Traditionally, fertility supplements have predominantly targeted women. However, there is a growing recognition of the importance of male reproductive health in fertility outcomes. As a result, the market is witnessing the emergence of male-specific fertility supplements designed to support sperm quality, motility, and overall reproductive wellness.

Diverse Product Formats

Fertility supplements are diversifying beyond traditional pill and capsule formats. Consumers are showing interest in alternative delivery methods, such as gummies, powders, and liquid formulations. These formats can offer convenience and variety, making it easier for individuals to incorporate supplements into their daily routines.

Segmental Insights

Ingredient Insights

Based on the category of Ingredient, the synthetic sector dominated in terms of revenue share in 2022. Notably, selenium, zinc, folic acid, vitamin C, vitamin B6, CoQ1, and Myo-Inositol played a significant role in driving overall growth because of heightened demand and their easy accessibility.

From 2023 to 2030, the natural segment is projected to experience substantial growth at a CAGR. This growth is expected to be propelled by the introduction of new products and technological advancements in the health and wellness industry. People are increasingly turning to plant-based products to maintain a healthy lifestyle and reduce the risk of side effects. There's a growing demand for plant extracts, especially herbs, in the pharmaceutical sector, driven by increased awareness of biologically sourced ingredients. However, this trend is likely to result in decreased availability of raw materials for natural food product manufacturers in the coming years.

Despite the rapid expansion of natural ingredients, a lack of scientific backing for claims has been a hindrance to this segment's growth. To address this, several governments have initiated studies to promote the adoption of natural products, which is expected to boost demand for such products in the foreseeable future.

End-use Insights

In 2022, the women's category held the largest market share. According to data from the Centers for Disease Control and Prevention, approximately 19% of women aged 15-49 with no prior childbirth history face challenges related to infertility. Notably, the highest prevalence of fertility issues was observed among married women aged 40 to 44, followed by those aged 35 to 39. Government and non-profit organizations have launched initiatives aimed at providing guidance and medical support, leading to increased awareness and creating opportunities for manufacturers in this market.

The men's segment is expected to witness significant growth at a CAGR during the forecast period. Some of the most common factors contributing to infertility in men include hypogonadism, immune system-related issues, varicocele, systemic diseases, sexual factors, undescended testicles, and urogenital infections. Notably, male factors are responsible for approximately 20% of all infertility cases and contribute to another 30% to 40%. According to a research paper published in the National Library of Medicine in 2022, male factors play a significant role in approximately 50% of all infertility cases, which is expected to drive demand for products in this segment in the coming years.

Regional Insights

In 2022, North America dominated the market in terms of revenue share. According to the December 2021 update from the Centers for Disease Control and Prevention (CDC), 13.1% of women aged 15 to 49 in the United States experienced fertility issues, while 14.1% of married women in the same age group faced fertility challenges. Additionally, 6% of married women were identified as infertile, which drove the demand for products in this region. Furthermore, in Canada, the market is expected to experience rapid growth due to increased efforts by the government and non-profit organizations like Fertility Matters Canada to raise awareness about fertility treatments and medications. The rising rates of obesity and sexually transmitted infections in Canada are also contributing to this growth.

Looking ahead, the Asia Pacific region is poised for substantial growth with a significant CAGR expected from 2023 to 2030. This region presents attractive opportunities for leading companies in the fertility supplement market, thanks to improved access to healthcare facilities and increased investment in research and healthcare sectors. The growing awareness of nutritional enrichment in countries like India and China is anticipated to be a key driver of regional growth. Additionally, regulatory support encouraging investment in the retail market in nations such as India, China, Indonesia, and Malaysia is expected to enhance consumer accessibility, thus facilitating market expansion in the region.

Key Market Players

Fairhaven Health LLC

Coastal Sciences

LENUS Pharma GesmbH

Orthomol Pharmazeutische Vertriebs GmbH

Exeltis USA Inc

PrepMe LLC

Bionova Inc

TTK Healthcare Ltd

Vitabiotics Ltd

VH Nutrition LLC

Report Scope:

In this report, the Global Fertility Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fertility Supplements Market, By Ingredient:

  • Natural
  • Synthetic/ Blend of Natural & Synthetic

Fertility Supplements Market, By Product:

  • Capsules
  • Tablets
  • Soft Gels
  • Powders
  • Liquids

Fertility Supplements Market, By End-use:

  • Men
  • Women

Fertility Supplements Market, By Distribution Channel:

  • OTC
  • Prescribed

Fertility Supplements Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Fertility Supplements Market.

Available Customizations:

  • Global Fertility Supplements market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fertility Supplements Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
    • 5.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
    • 5.2.3. By End-use (Men, Women)
    • 5.2.4. By Distribution Channel (OTC, Prescribed)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Market Map
    • 5.3.1. By Ingredient
    • 5.3.2. By Product
    • 5.3.3. By End-use
    • 5.3.4. By Distribution Channel
    • 5.3.5. By Region

6. North America Fertility Supplements Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
    • 6.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
    • 6.2.3. By End-use (Men, Women)
    • 6.2.4. By Distribution Channel (OTC, Prescribed)
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fertility Supplements Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Ingredient
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By End-use
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Fertility Supplements Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Ingredient
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By End-use
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Fertility Supplements Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Ingredient
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By End-use
        • 6.3.3.2.4. By Distribution Channel

7. Europe Fertility Supplements Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
    • 7.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
    • 7.2.3. By End-use (Men, Women)
    • 7.2.4. By Distribution Channel (OTC, Prescribed)
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Fertility Supplements Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Ingredient
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By End-use
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. United Kingdom Fertility Supplements Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Ingredient
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By End-use
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. France Fertility Supplements Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Ingredient
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By End-use
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Fertility Supplements Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Ingredient
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By End-use
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Fertility Supplements Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Ingredient
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By End-use
        • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Fertility Supplements Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
    • 8.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
    • 8.2.3. By End-use (Men, Women)
    • 8.2.4. By Distribution Channel (OTC, Prescribed)
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Fertility Supplements Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Ingredient
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By End-use
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. Japan Fertility Supplements Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Ingredient
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By End-use
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. India Fertility Supplements Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Ingredient
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By End-use
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Australia Fertility Supplements Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Ingredient
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By End-use
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. South Korea Fertility Supplements Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Ingredient
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By End-use
        • 8.3.5.2.4. By Distribution Channel

9. South America Fertility Supplements Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
    • 9.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
    • 9.2.3. By End-use (Men, Women)
    • 9.2.4. By Distribution Channel (OTC, Prescribed)
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Fertility Supplements Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Ingredient
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By End-use
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Fertility Supplements Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Ingredient
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By End-use
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Fertility Supplements Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Ingredient
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By End-use
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Fertility Supplements Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
    • 10.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
    • 10.2.3. By End-use (Men, Women)
    • 10.2.4. By Distribution Channel (OTC, Prescribed)
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Fertility Supplements Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Ingredient
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By End-use
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Fertility Supplements Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Ingredient
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By End-use
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Fertility Supplements Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Ingredient
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By End-use
        • 10.3.3.2.4. By Distribution Channel
    • 10.3.4. Kuwait Fertility Supplements Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Ingredient
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By End-use
        • 10.3.4.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Fairhaven Health LLC
    • 14.6.2. Coastal Sciences
    • 14.6.3. LENUS Pharma GesmbH
    • 14.6.4. Orthomol Pharmazeutische Vertriebs GmbH
    • 14.6.5. Exeltis USA Inc
    • 14.6.6. PrepMe LLC
    • 14.6.7. Bionova Inc
    • 14.6.8. TTK Healthcare Ltd
    • 14.6.9. Vitabiotics Ltd
    • 14.6.10. VH Nutrition LLC

15. Strategic Recommendations

16. About Us & Disclaimer